NHS Waiting Lists: How the Recovery Plan Is Actually Progressing

Two things are true about NHS elective waiting times, and most disagreement about them comes from picking one and ignoring the other. The list is coming down and the longest waits have fallen dramatically. The constitutional standard that 92 per cent of patients should be treated within 18 weeks remains far out of reach. Both statements describe April 2026 accurately.

The detail: 7.2 million pathways were waiting, covering roughly 6.1 million individual patients — the difference reflects patients waiting for more than one treatment. Of those, 65.0 per cent had been waiting less than 18 weeks. Just under 100,000 pathways — 99,781 — had exceeded 52 weeks. At the extreme end, 5,776 had passed 65 weeks and 191 had passed 104 weeks.

The direction of travel

March 2026 was the more significant month politically, because performance reached 65.3 per cent and met the government’s interim target of 65 per cent. The list stood at 7.11 million, its lowest level in three and a half years, down around 515,000 since July 2024. Waits beyond 52 weeks have fallen by 69 per cent over the recovery period. Those are substantial movements in a system of this size, achieved while industrial action cost approximately 171,776 appointments and procedures.

Monthly referral-to-treatment figures are published in full by NHS England, including breakdowns by specialty and by provider — which is where the national averages become genuinely misleading, since performance varies enormously between specialties and regions.

Why 92 per cent is the hard part

The 92 per cent standard is now due to be met by March 2029. Moving from 65 per cent to 92 per cent is not a continuation of current progress; it is a substantially harder problem. The gains achieved so far came largely from clearing the longest waiters, where the clinical and political imperative was clearest and where dedicated capacity could be directed at a defined backlog.

Reaching 92 per cent requires the entire distribution to shift, which means sustained throughput across every specialty rather than targeted intervention in the worst areas. It also requires referral volumes to stabilise, and they have not — demand for elective care has grown consistently, so the system is running to stand still before it starts gaining ground. The reform programme is set out in the government’s elective care reform plan, which leans heavily on community diagnostic capacity and surgical hubs.

Cancer and emergency care are further behind

Elective waiting is not the weakest area. Cancer performance stood at 69.6 per cent against an 85 per cent standard — a gap of comparable size to the elective one but with far more acute clinical consequences, since delay in cancer pathways translates directly into worse outcomes rather than prolonged discomfort.

Emergency care recorded 75.7 per cent of A&E attendances within four hours in June 2026, against a 78 per cent interim target and a 95 per cent constitutional standard. The 95 per cent figure has not been met nationally for a decade, and there is no current plan with a date attached for returning to it. Independent analysis tracking these series over time is maintained by The King’s Fund.

What patients can reasonably do

Patients have more rights within the referral system than most realise, and exercising them can materially change a wait. If you have been waiting more than 18 weeks for consultant-led treatment, you are entitled to ask to be referred to an alternative provider with a shorter wait, including independent sector providers commissioned by the NHS. Waiting times differ substantially between hospitals for the same procedure.

Keep contact details current with the referring service. A meaningful proportion of appointment slots are lost because patients cannot be reached, and a missed contact frequently returns the pathway to the back of a queue. If your condition changes while waiting, tell the service — clinical prioritisation is reviewed, but only on the basis of information the service actually has.

The fair assessment of where the NHS stands is that the recovery is real, measurable and slower than the headline targets imply. A list falling by half a million while demand rises is not a small achievement. A system treating 65 per cent of patients within a standard set at 92 per cent is also not a functioning one by its own definition. Both facts will continue to be quoted selectively for the next three years.